Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARWR | ZTS | TAK | NBIX | UTHR |
| Company | Arrowhead Pharma | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Neurocrine Bioscienc | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 62.00 | 122.53 | 15.91 | 130.22 | 460.98 |
| High | 65.33 | 125.72 | 16.25 | 134.77 | 470.98 |
| Low | 61.65 | 121.65 | 15.91 | 129.17 | 455.63 |
| Latest | 65.28 | 123.24 | 16.15 | 134.54 | 468.07 |
| Change | +1.44 | -0.88 | -0.01 | +2.15 | +3.14 |
| % Change | +2.26% | -0.71% | -0.06% | +1.62% | +0.68% |
| Volume | 1,415,300 | 5,443,100 | 4,847,100 | 1,057,000 | 420,300 |
| 20-Day Average Volume | 2,606,075 | 4,686,915 | 2,631,065 | 1,096,755 | 420,935 |
| Previous Close | 63.84 | 124.12 | 16.16 | 132.39 | 464.93 |
| Industry | Medical - Biomedical | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 67.05 | 125.64 | 15.84 | 139.24 | 492.82 |
| 20-Day Raw Stochastic | 28.87% | 21.18% | 81.03% | 27.69% | 19.33% |
| 20-Day Relative Strength | 55.11 | 44.86 | 65.00 | 41.44 | 43.39 |
| Weighted Alpha | +228.55 | -28.46 | +24.15 | -4.47 | +25.29 |
| Today's Opinion | 80% Buy | 56% Sell | 88% Buy | 8% Sell | 56% Buy |
| Previous Opinion | 80% Buy | 56% Sell | 88% Buy | 8% Sell | 56% Buy |
| Last Month's Opinion | 100% Buy | 88% Sell | 24% Sell | 64% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.99% since 01/12/26 | -1.66% since 01/12/26 | -0.68% since 01/12/26 | +1.42% since 01/12/26 | -2.97% since 01/12/26 |
| Low | 61.65 on 01/20/26 | 121.65 on 01/20/26 | 15.87 on 01/13/26 | 129.17 on 01/20/26 | 455.63 on 01/20/26 |
| High | 68.44 on 01/13/26 | 126.50 on 01/14/26 | 16.48 on 01/14/26 | 135.98 on 01/15/26 | 484.22 on 01/13/26 |
| 1-Month | |||||
| %Chg | -4.23% since 12/19/25 | +0.82% since 12/19/25 | +8.39% since 12/19/25 | -7.21% since 12/19/25 | -9.49% since 12/19/25 |
| Low | 60.62 on 01/05/26 | 121.12 on 12/22/25 | 14.85 on 12/22/25 | 129.17 on 01/20/26 | 455.63 on 01/20/26 |
| High | 76.76 on 01/06/26 | 131.13 on 01/06/26 | 16.48 on 01/14/26 | 148.56 on 12/23/25 | 519.99 on 12/23/25 |
| 3-Month | |||||
| %Chg | +69.69% since 10/20/25 | -15.04% since 10/20/25 | +14.70% since 10/20/25 | -4.80% since 10/20/25 | +8.18% since 10/20/25 |
| Low | 36.73 on 10/23/25 | 115.25 on 11/19/25 | 12.99 on 10/30/25 | 129.17 on 01/20/26 | 409.07 on 10/28/25 |
| High | 76.76 on 01/06/26 | 148.30 on 10/22/25 | 16.48 on 01/14/26 | 160.18 on 12/08/25 | 519.99 on 12/23/25 |
| 6-Month | |||||
| %Chg | +289.50% since 07/18/25 | -17.07% since 07/18/25 | +11.92% since 07/18/25 | +1.91% since 07/18/25 | +60.29% since 07/18/25 |
| Low | 14.30 on 07/22/25 | 115.25 on 11/19/25 | 12.99 on 10/30/25 | 123.67 on 08/08/25 | 272.12 on 07/31/25 |
| High | 76.76 on 01/06/26 | 160.48 on 08/20/25 | 16.48 on 01/14/26 | 160.18 on 12/08/25 | 519.99 on 12/23/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,674,579 | 54,932,380 | 51,420,736 | 13,200,078 | 20,018,486 |
| Shares Outstanding, K | 135,880 | 440,693 | 3,181,976 | 99,706 | 43,057 |
| Annual Sales | 829,450,000 | 9,256,000,000 | 30,238,240,000 | 2,355,300,000 | 2,877,400,000 |
| Annual Net Income | -1,630,000 | 2,486,000,000 | 712,320,000 | 341,300,000 | 1,195,100,000 |
| Last Quarter Sales | 256,470,000 | 2,400,000,000 | 7,718,640,000 | 794,900,000 | 799,500,000 |
| Last Quarter Net Income | -23,750,000 | 721,000,000 | -81,860,000 | 209,500,000 | 338,700,000 |
| 60-Month Beta | 1.21 | 0.97 | 0.03 | 0.28 | 0.84 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 11/25/25 | 1.70 on 11/04/25 | 0.44 on 10/30/25 | 2.04 on 10/28/25 | 7.16 on 10/29/25 |
| Latest Earnings Date | 02/09/26 | 02/12/26 | 01/29/26 | 02/05/26 | 02/25/26 |
| Most Recent Dividend | N/A | 0.530 on 01/20/26 | 0.252 on 09/30/25 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 01/20/26 | 09/30/25 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.76 | 10.60 | 31.90 | 17.89 |